uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
Show others and affiliations
2013 (English)In: Neurobiology of Disease, ISSN 0969-9961, E-ISSN 1095-953X, Vol. 51, no SI, 177-191 p.Article in journal (Refereed) Published
Abstract [en]

It is widely accepted that the angiotensin AT2-receptor (AT2R) has neuroprotective features. In the present study we tested pharmacological AT2R-stimulation as a therapeutic approach in a model of spinal cord compression injury (SCI) in mice using the novel non-peptide AT2R-agonist, Compound 21 (C21). Complementary experiments in primary neurons and organotypic cultures served to identify underlying mechanisms. Functional recovery and plasticity of corticospinal tract (CST) fibers following SCI were monitored after application of C21 (0.3. mg/kg/day. i.p.) or vehicle for 4. weeks. Organotypic co-culture of GFP-positive entorhinal cortices with hippocampal target tissue served to evaluate the impact of C21 on reinnervation. Neuronal differentiation, apoptosis and expression of neurotrophins were investigated in primary murine astrocytes and neuronal cells.C21 significantly improved functional recovery after SCI compared to controls, and this significantly correlated with the increased number of CST fibers caudal to the lesion site. In vitro, C21 significantly promoted reinnervation in organotypic brain slice co-cultures (+50%) and neurite outgrowth of primary neurons (+25%). C21-induced neurite outgrowth was absent in neurons derived from AT2R-KO mice. In primary neurons, treatment with C21 further induced RNA expression of anti-apoptotic Bcl-2 (+75.7%), brain-derived neurotrophic factor (BDNF) (+53.7%), the neurotrophin receptors TrkA (+57.4%) and TrkB (+67.9%) and a marker for neurite growth, GAP43 (+103%), but not TrkC. Our data suggest that selective AT2R-stimulation improves functional recovery in experimental spinal cord injury through promotion of axonal plasticity and through neuroprotective and anti-apoptotic mechanisms. Thus, AT2R-stimulation may be considered for the development of a novel therapeutic approach for the treatment of spinal cord injury.

Place, publisher, year, edition, pages
2013. Vol. 51, no SI, 177-191 p.
Keyword [en]
Angiotensin, AT2-receptor, New therapies, Spinal cord injury
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-194838DOI: 10.1016/j.nbd.2012.11.008ISI: 000314627100020OAI: oai:DiVA.org:uu-194838DiVA: diva2:606777

De två första författarna delar förstaförfattarskapet.

De två sista författarna delar sistaförfattarskapet.

Available from: 2013-02-20 Created: 2013-02-19 Last updated: 2013-03-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Hallberg, Anders
By organisation
Organic Pharmaceutical Chemistry
In the same journal
Neurobiology of Disease
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 126 hits
ReferencesLink to record
Permanent link

Direct link